Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Artios Pharma Ltd
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Filamon LTD
AstraZeneca
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Fondazione del Piemonte per l'Oncologia
Dana-Farber Cancer Institute
PMV Pharmaceuticals, Inc
AstraZeneca
Dana-Farber Cancer Institute
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
NeoImmuneTech
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Rutgers, The State University of New Jersey
Qilu Pharmaceutical Co., Ltd.
AstraZeneca
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Aveni Foundation
Bayer
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
ViroMissile, Inc.
Arcus Biosciences, Inc.
Terremoto Biosciences Inc.
Cancer Research UK
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Kaiser Permanente
Children's Oncology Group
AstraZeneca
Pfizer
Duke University
A2 Biotherapeutics Inc.
AstraZeneca
M.D. Anderson Cancer Center
Arvinas Inc.
Zhejiang University
Tizona Therapeutics, Inc
University of Florida
Essen Biotech